Netherlands· NL-d6f7fa8f2af2

Trafloxal oogzalf, oogzalf 3 mg/ml

A ofloxacin product containing ofloxacine, registered in Netherlands by Bausch + Lomb Ireland Limited. The same ATC class is registered in 11 of our 19 countries.

ATC S01AE01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ofloxacineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ofloxacin is registered in 11 of 19 countries.

Countries holding a registration under ATC S01AE01 (ofloxacin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search ofloxacin products by name

Ofloxacin · ATC S01AE01

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Finlandprice
Germany
Ireland
Netherlands
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ofloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.4 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ofloxacin · price per daily dose (0.4 mg)

USD · FX 28 Sept 2026

FR France$0.0016

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: OFLOXACINE
Manufacturer: Bausch + Lomb Ireland Limited
Country: Netherlands (NL)
ATC code: S01AE01
ATC class: Ofloxacin
Defined daily dose: 0.4 mg, AT
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
13511

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ofloxacin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ofloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Floxal, Floxal Edo
Belgium · Trafloxal, Trafloxal Edo
Bulgaria · Медофлоксин, Офлоксацин Дра
Cyprus · Cilox, Medofloxine
Czechia · Floxal, Ofloxacin Unimed Pharma
Germany · Floxal, Floxal Edo
Estonia · Medofloxine, Ofloxin
Spain · Exocin, Oflovir
Finland · Exocin
France · Exocine, Monoflocet
United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
Greece · Exocin, Oxatrex
Croatia · Uniflox
Hungary · Floxal, Grenis-Oflo
Ireland · Exocin
Italy · Dunaflot, Exocin
Lithuania · Ofloxin, Uniflox
Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
Latvia · Ofloxin, Uniflox
Malta · Uniflox Unimed Pharma
Poland · Floxal, Oflodinex
Portugal · Audret, Bioquil
Romania · Floxal, Ofloxacină Laropharm
Sweden · Ofloxacin Mibe
Slovakia · Medofloxine, Ofloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b2b5fef8-246f-4dad-a0bb-914dd01f6eb4
GET /v1/drugs/b2b5fef8-246f-4dad-a0bb-914dd01f6eb4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogzalf",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h13511_smpc.pdf",
  "strength": null,
  "atc_label": "Ofloxacin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg13511",
  "excipients": [
    "PARAFFINE, VLOEIBAAR (E905)",
    "PARAFFINE, ZACHT (E 905)",
    "WOLVET"
  ],
  "substances": [
    "OFLOXACINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h13511.pdf",
  "authorised_at": "1990/07/24",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "13511",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about ofloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console